Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Plant Direct|March 9, 2023
A complex role of Arabidopsis CDKD;3 in meiotic progression and cytokinesisSorin Tanasa, Neha Shukla, Albert Cairo, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage IIIMarkus Stana, Brane Grambozov, Christoph Gaisberger, et al.
Cancers|April 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis RateMarkus Stana, Brane Grambozov, Josef Karner, et al.
Cancers|February 15, 2022
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLCBrane Grambozov, Markus Stana, Bernhard Kaiser, et al.
Life Science Alliance|June 5, 2019
Molecular characterization of Chlamydomonas reinhardtii telomeres and telomerase mutantsStephan Eberhard, Sona Valuchova, Julie Ravat, et al.
Genes|December 1, 2020
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast CancerBarbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Clinical Epigenetics|March 11, 2016
Hsa-miR-375 is a predictor of local control in early stage breast cancerFranz Zehentmayr, Cornelia Hauser-Kronberger, Barbara Zellinger, et al.
Biomedicines|August 28, 2025
Delta Changes in [18F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-ChemoimmunotherapyBrane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, et al.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Brain Tumor Pathology|January 12, 2022
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literatureTheo F J Kraus, Christoph Schwartz, Lukas Machegger, et al.
Pageof 7